Maribavir for Prevention of CMV After Stem Cell Transplants

Clinical trial NCT00223925 · COMPLETED

Trial details

NCT number: NCT00223925
Sponsor: Shire
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cytomegalovirus Infection

Start date: 2004-10-28
Primary completion: 2006-04-05
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.